Transfusion-Transmissible Infections Monitoring System (TTIMS)

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
75F40125Q00337
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Food and Drug Administration's Center for Biologics Evaluation and Research is procuring comprehensive services for the Transfusion-Transmissible Infections Monitoring System (TTIMS), which will develop and maintain a surveillance system to monitor transfusion-transmissible infections among U.S. blood donors. The system will focus on tracking HIV, Hepatitis C, Hepatitis B, and Syphilis infections, analyzing data from approximately 60% of the U.S. blood supply across multiple blood centers. Key requirements include collecting and analyzing blood donation data, maintaining a specimen repository, conducting laboratory testing, performing risk factor analyses, and preparing technical reports while ensuring compliance with extensive information security, privacy, and personnel screening requirements. The government will evaluate proposals based on technical capability, past performance, and price, with technical and past performance weighted as relatively more important than price. Proposals are due August 22, 2025, for this solicitation numbered 75F40125Q00337.

This procurement does not utilize any small business set-aside designations and will be awarded as a firm-fixed-price contract structure. The contract includes a base year with three one-year option periods, spanning from September 25, 2025 through September 24, 2029, for a total potential duration of four years. The contractor will be responsible for monitoring transfusion-transmissible infections at participating blood collection organizations and must provide appropriate biohazard containment facilities along with qualified key personnel and subcontractors. Monthly progress reports and semi-annual/annual technical reports containing aggregated infection data will be required deliverables throughout the contract performance period. The work will be performed within the United States, and contractors must demonstrate the capability to execute all tasks and deliverables associated with this specialized monitoring and surveillance system.

Notice text

The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection Monitoring System (TTIMS) services.

Please review the attached solicitation and other documents. If interested, please follow the instructions written in the solicitation.

Offerors must be able to successfully execute all of the tasks and deliverables of this requirement.  

Files

File Type Posted
Sol_QR_75F40125Q00337_Responses.pdf PDF
Sol_Doc_75F40125Q00337.pdf PDF
Form FDA 3398.pdf PDF
HHS Subcontracting Plan.pdf PDF
Past Performanc Evaluation Questionnaire.docx DOCX document

Notice history

Notice Type Posted
Transfusion-Transmissible Infections Monitoring System (TTIMS) Award Award Notice
This notice Latest solicitation Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
BPA - Blood Transfusion Services Wright Patterson AFB, Ohio 45433, United States · NAICS 621991 AFLCMC Wright Patterson AFB No set-aside
Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC) Captain James A. Lovell Federal Health Care Center Fhcc North Chicago, Illinois 60064, United States · NAICS 621511 Veterans Integrated Service Network 12 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors